Document is current
Any future updates will be listed below
-
Authors
Eley, Sarah E. A.
Weissgold, Sydni
Stanfield, Andrew C.
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 9 June 2025
First Online: 1 September 2025
Declarations
:
: The study was reviewed by Edinburgh medical school research ethics committee (EMREC) with favourable opinion granted on 25th April 2024 (REC Reference: 24-EMREC-011). Study participation was voluntary and confidential. Data collection occurred between May and July 2024.
: ACS has received grants and consultancy fees paid to the University of Edinburgh from Novartis, Roche, Shionogi, Enthorin Therapuetics and Zynerba.
